Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVectura Share News (VEC)

Share Price Information for Vectura (VEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 119.00
Bid: 118.80
Ask: 119.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.17%)
Open: 113.40
High: 120.20
Low: 113.40
Yest. Close: 119.00
VEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Vectura Revenue Slips But Swings To First Half Profit

Tue, 15th Sep 2020 17:22

(Alliance News) - Vectura Group PLC on Tuesday posted a slight first-half revenue fall but said its 2020 is "on track" despite Covid-19.

London-based Vectura, which makes things such as inhalers, said its revenue in the six months to June 30 slipped 2.2% annually to GBP89.7 million from GBP91.7 million.

The soon-to-be FTSE 250 outfit swung to a pretax profit of GBP3.2 million from a GBP13.4 million loss a year earlier.

"I am pleased to report that financial performance for 2020 is on-track, with our base business proving resilient in the face of wider challenges posed by the Coronavirus outbreak. We are continuing to execute on our inhalation contract development and manufacturing organisation strategy and have signed 12 new deals to date, revenue from which will begin to feed through in the second half of the year," Chief Executive Officer Will Downie said.

Vectura will leave the small cap ranks and enter the FTSE 250 following an index review earlier in September. The changes take effect from September 21.

Vectura shares closed up 1.6% at 115.00 pence each in London on Tuesday.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

21 Apr 21 10:06

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

19 Mar 21 09:46

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

18 Mar 21 10:36

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

18 Mar 21 07:43

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

11 Mar 21 16:13

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

5 Mar 21 12:29

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

2 Mar 21 16:01

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

22 Jan 21 09:32

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

12 Jan 21 10:13

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

12 Jan 21 08:16

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

30 Dec 20 19:10

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

29 Dec 20 12:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

29 Dec 20 10:04

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

18 Dec 20 17:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

18 Dec 20 12:08

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.